中西医治疗局限性硬皮病的研究进展

Progress in the Treatment of Limited Scleroderma with Traditional Chinese and Western Medicine

硬皮病是一种罕见的结缔组织疾病,通常出现皮肤变性、增厚、纤维化进而硬化或萎缩等特征,此病可引起多系统或局部损害,在我国硬皮病的发病率仅次于类风湿性关节炎和系统性红斑狼疮。随着临床的深入研究,已证实硬皮病可分为局限性硬皮病和系统性硬皮病两大类。近年来,局限性硬皮病的发病率逐年上升,同时其危害性也在显著增加。目前,西医对该病症尚无切实有效的治愈方法,但若结合中医药的使用可给局限性硬皮病的治疗带来新的思路和转机。本文从局限性硬皮病的分类,与系统性硬皮病的区别,局限性硬皮病的诊断,中西医药治疗局限性硬皮病的方法等方面进行了详细的分析和总结,阐述了中西医药治疗局限性硬皮病的特点,希望为局限性硬皮病的预防、诊断和治疗提供一定的理论参考及依据。

Scleroderma is a rare connective tissue disease,usually characterized by skin degeneration,thickening,fibrosis and then sclerosis or atrophy.Scleroderma can cause multiple system or local damage.The incidence of scleroderma in China is second only to rheumatoid arthritis and systemic lupus erythematosus.With the in-depth clinical research,it has been confirmed that scleroderma can be divided into two categories:localized scleroderma and systemic scleroderma.In recent years,the incidence of localized scleroderma has increased year by year,and its harmfulness has also increased significantly.At present,there is no effective cure for this disease in Western medicine,but the combination of traditional Chinese medicine can bring new ideas and opportunities for the treatment of localized scleroderma.In this paper,the classification of localized scleroderma,the difference between systemic scleroderma and localized scleroderma,the diagnosis of localized scleroderma and the treatment of localized scleroderma with traditional Chinese and Western medicine are analyzed and summarized in detail.The characteristics of the treatment of localized scleroderma with traditional Chinese and Western medicine are elaborated,hoping to provide some theoretical reference and basis for the prevention,diagnosis and treatment of localized scleroderma.